Human colon cancer cells injected into mice form tumors (left) consisting of both MAPK-active cells (green) and NOTCH-active cells (red). Treatment with the MAPK inhibitor selumetinib results in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results